DRTS NASDAQ
Alpha Tau Medical Ltd
1W: +1.6%
1M: +3.1%
3M: +8.8%
YTD: +205.8%
1Y: +238.0%
3Y: +333.1%
5Y: +49.6%
$14.77
+0.26 (+1.79%)
Weekly Expected Move ±5.3%
$13
$14
$15
$16
$16
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$27M
-34.9% ▼
Capital Expenditures
$6M
-171.4% ▼
5Y CAGR: +10.0%
Free Cash Flow
-$33M
-48.7% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$1M
-185.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$27M | -$34M | -$29M | -$32M | -$43M |
| Depreciation & Amort. | $776K | $979K | $1M | $1M | $1M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $585K | -$307K | $2M | $1M | $2M |
| Other Non-Cash Items | $14M | $9M | $8M | $10M | $12M |
| Operating Cash Flow | -$12M | -$24M | -$18M | -$20M | -$27M |
| — Investing Activities — | |||||
| Capital Expenditures | -$3M | -$904K | -$6M | -$2M | -$6M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | -$125M | -$70M |
| Investment Sales | $0 | $0 | $0 | $148M | $56M |
| Other Investing | $22M | -$89M | $25M | -$103K | $0 |
| Investing Cash Flow | $19M | -$90M | $19M | $21M | -$21M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $94M | $5M | $0 | $0 |
| Financing Cash Flow | $111K | $97M | $5M | $25K | $46M |
| Net Change in Cash | $8M | -$17M | $9M | $1M | -$1M |
| Cash End of Period | $24M | $7M | $16M | $17M | $16M |
| Free Cash Flow | -$15M | -$25M | -$24M | -$22M | -$33M |